Protective effect of kaempferol glucoside against lipopolysaccharide-caused acute lung injury via targeting Nrf2/NF-κB/NLRP3/GSDMD: Integrating experimental and computational studies
-
Published:2024-06
Issue:6
Volume:32
Page:102073
-
ISSN:1319-0164
-
Container-title:Saudi Pharmaceutical Journal
-
language:en
-
Short-container-title:Saudi Pharmaceutical Journal
Author:
Abdulaal Wesam H.,
Omar Ulfat M.ORCID,
Zeyadi MustafaORCID,
El-Agamy Dina S.ORCID,
Alhakamy Nabil A.,
A. R. Almalki Naif,
Asfour Hani Z.,
Al-Rabia Mohammed W.,
Alzain Abdulrahim A.ORCID,
Mohamed Gamal A.,
Ibrahim Sabrin R.M.
Reference47 articles.
1. Euphorbi acuneata represses LPS-induced acute lung injury in mice via its antioxidative and anti-inflammatory activities;Abdallah;Plants,2020
2. Pulicaria petiolaris effectively attenuates lipopolysaccharide (LPS)-induced acute lung injury in mice;Ahmed;Arch. Biol. Sci.,2018
3. A randomized, placebo-controlled trial evaluating the safety of excessive administration of kaempferol aglycone;Akiyama;Food Sci. Nutr.,2023
4. Hepatoprotective effect of kaempferol: a review of the dietary sources, bioavailability, mechanisms of action, and safety;Alkandahri;Adv. Pharmacol. Pharm. Sci.,2023
5. Modulation of NRF2/KEAP1-mediated oxidative stress for cancer treatment by natural products using pharmacophore-based screening, molecular docking, and molecular dynamics studies;Alzain;Molecules,2023